Kummar S - Search Results

1

Next generation oncology drug development: opportunities and challenges.

Gutierrez ME, Kummar S, Giaccone G. Gutierrez ME, et al. Among authors: kummar s. Nat Rev Clin Oncol. 2009 May;6(5):259-65. doi: 10.1038/nrclinonc.2009.38. Nat Rev Clin Oncol. 2009. PMID: 19390552 Free PMC article. Review.

2

A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer.

Murren J, Modiano M, Kummar S, Clairmont C, Egorin M, Chu E, Sznol M. Murren J, et al. Among authors: kummar s. Invest New Drugs. 2005 Mar;23(2):123-35. doi: 10.1007/s10637-005-5857-6. Invest New Drugs. 2005. PMID: 15744588 Clinical Trial.

3

False elevations in prostate-specific antigen levels affecting patient management.

Kummar S, Shafi NQ. Kummar S, et al. Clin Adv Hematol Oncol. 2004 Sep;2(9):599-601; discussion 602. Clin Adv Hematol Oncol. 2004. PMID: 16163243 No abstract available.

4

Non-small-cell lung cancer vaccine therapy: a concise review.

O'Mahony D, Kummar S, Gutierrez ME. O'Mahony D, et al. Among authors: kummar s. J Clin Oncol. 2005 Dec 10;23(35):9022-8. doi: 10.1200/JCO.2005.02.3101. Epub 2005 Oct 11. J Clin Oncol. 2005. PMID: 16219932 Review.

5

Drug development in oncology: classical cytotoxics and molecularly targeted agents.

Kummar S, Gutierrez M, Doroshow JH, Murgo AJ. Kummar S, et al. Br J Clin Pharmacol. 2006 Jul;62(1):15-26. doi: 10.1111/j.1365-2125.2006.02713.x. Br J Clin Pharmacol. 2006. PMID: 16842375 Free PMC article. Review.

6

Compressing drug development timelines in oncology using phase '0' trials.

Kummar S, Kinders R, Rubinstein L, Parchment RE, Murgo AJ, Collins J, Pickeral O, Low J, Steinberg SM, Gutierrez M, Yang S, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH. Kummar S, et al. Nat Rev Cancer. 2007 Feb;7(2):131-9. doi: 10.1038/nrc2066. Nat Rev Cancer. 2007. PMID: 17251919 Review.

7

Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.

Kummar S, Gutierrez M, Gardner ER, Donovan E, Hwang K, Chung EJ, Lee MJ, Maynard K, Kalnitskiy M, Chen A, Melillo G, Ryan QC, Conley B, Figg WD, Trepel JB, Zwiebel J, Doroshow JH, Murgo AJ. Kummar S, et al. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5411-7. doi: 10.1158/1078-0432.CCR-07-0791. Clin Cancer Res. 2007. PMID: 17875771 Clinical Trial.

8

Role of insulin-like growth factor-1R system in colorectal carcinogenesis.

Donovan EA, Kummar S. Donovan EA, et al. Among authors: kummar s. Crit Rev Oncol Hematol. 2008 May;66(2):91-8. doi: 10.1016/j.critrevonc.2007.09.003. Epub 2007 Oct 31. Crit Rev Oncol Hematol. 2008. PMID: 17977741 Free PMC article. Review.

9

Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.

Kinders R, Parchment RE, Ji J, Kummar S, Murgo AJ, Gutierrez M, Collins J, Rubinstein L, Pickeral O, Steinberg SM, Yang S, Hollingshead M, Chen A, Helman L, Wiltrout R, Simpson M, Tomaszewski JE, Doroshow JH. Kinders R, et al. Among authors: kummar s. Mol Interv. 2007 Dec;7(6):325-34. doi: 10.1124/mi.7.6.9. Mol Interv. 2007. PMID: 18199854 Review.

10

Phase 0 clinical trials: conceptions and misconceptions.

Kummar S, Rubinstein L, Kinders R, Parchment RE, Gutierrez ME, Murgo AJ, Ji J, Mroczkowski B, Pickeral OK, Simpson M, Hollingshead M, Yang SX, Helman L, Wiltrout R, Collins J, Tomaszewski JE, Doroshow JH. Kummar S, et al. Cancer J. 2008 May-Jun;14(3):133-7. doi: 10.1097/PPO.0b013e318172d6f3. Cancer J. 2008. PMID: 18536551 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results